Top 50 Medical Device VC Funds & Investors in Asia (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Qiming Venture Partners
VC Fund
|
14 | China, United States, Hong Kong | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5M–$134M |
|
Cowin Capital
VC Fund
|
13 | China, Hong Kong, United States | Series A, Series B, Seed | Manufacturing, Health Care, Biotechnology | $1.4M–$50M |
|
HSG
VC Fund
|
12 | China, United States, Hong Kong | Series A, Series B, Series C | Health Care, Biotechnology, Software | $4.4M–$214M |
|
BioVenture
VC Fund
|
11 | China, United States, Hong Kong | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $3M–$73M |
|
Shunwei Capital
VC Fund
|
11 | China, United States, India | Series A, Series B, Series C | Manufacturing, Software, Internet | $1.4M–$100M |
|
Lilly Asia Ventures
VC Fund
|
10 | China, United States, Hong Kong | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $14M–$283M |
|
BioTrack Capital
VC Fund
|
10 | China, United States, Singapore | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $14M–$168M |
|
CD Capital
VC Fund
|
10 | China, United States | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.4M–$34M |
|
Addor Capital
VC Fund
|
9 | China, Hong Kong, Singapore | Series A, Series B, Seed | Manufacturing, Semiconductor, Electronics | $1.4k–$43M |
|
Prox Ventures
VC Fund
|
9 | China, United States, United Kingdom | Seed, Series A | Medical, Biotechnology, Health Care | $1.9M–$28M |
|
BIOCHING CAPITAL
VC Fund
|
9 | China | Angel, Series A, Seed | Medical, Medical Device, Biotechnology | $425k–$15M |
|
Taiyu Investment
VC Fund
|
9 | China | Seed, Series A, Angel | Medical, Health Care, Biotechnology | $4.1M–$37M |
|
UntroD Capital
VC Fund
|
9 | Japan, Singapore, Austria | Seed, Series A | Manufacturing, Biotechnology, Health Care | $772k–$241M |
|
IDG Capital
VC Fund
|
8 | China, United States, India | Series A, Series B, Series C | Software, Internet, E-Commerce | $3M–$200M |
|
Haibang Capital
VC Fund
|
8 | China | Series A, Series B, Angel | Biotechnology, Health Care, Manufacturing | $425k–$71M |
|
EFung Capital
VC Fund
|
8 | China, United States, India | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $1.4M–$87M |
|
Dalton Venture
VC Fund
|
7 | China, India, Canada | Seed, Series A, Series B | Health Care, Medical, Biotechnology | $450k–$47M |
|
Fast Track Initiative, Inc.
VC Fund
|
7 | Japan, United States, United Kingdom | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $1.2M–$184M |
|
Mitsubishi UFJ Capital
VC Fund
|
7 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Health Care | $952k–$269M |
|
Med-Fine Capital
VC Fund
|
7 | China, Hong Kong, United States | Series A, Seed, Series B | Medical, Health Care, Biotechnology | $2.8M–$60M |
|
Legend Capital
VC Fund
|
7 | China, United States, South Korea | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $2.9M–$156M |
|
Oriza Seed Capital (Oriza Yuandian)
VC Fund
|
7 | China, United States, Singapore | Series A, Seed, Angel | Manufacturing, Health Care, Medical | $213k–$60M |
|
Marathon Venture Partners
VC Fund
|
6 | China, United States, Hong Kong | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $1.4M–$462M |
|
SBI Investment
VC Fund
|
6 | Japan, South Korea, United States | Series B, Series A | Software, Information Technology, Financial Services | $2M–$227M |
|
Matrix Partners China
VC Fund
|
6 | China, United States, Singapore | Series A, Series B, Seed | Health Care, Biotechnology, Software | $1.6M–$113M |
|
Share Capital
VC Fund
|
6 | China, United States, Colombia | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $142k–$57M |
|
SND Ventures Group
VC Fund
|
6 | China | Series A, Series B, Seed | Manufacturing, Semiconductor, Health Care | $1.4M–$28M |
|
Oriza Holdings
VC Fund
|
6 | China, United States, Canada | Series A, Series B, Series C | Manufacturing, Health Care, Biotechnology | $1.7M–$200M |
|
JAFCO
VC Fund
|
6 | Japan, United States, Israel | Series A, Series B | Information Technology, Software, Artificial Intelligence | $1.9M–$198M |
|
SZHTI Group
VC Fund
|
6 | China, United States | Series A, Angel | Manufacturing, Electronics, Semiconductor | $425k–$14M |
|
Highlight Capital
VC Fund
|
6 | China, United States, South Korea | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $2.8M–$74M |
|
CDH Investments
VC Fund
|
6 | China, United States, Canada | Series A, Series B, Series C | Manufacturing, Biotechnology, Health Care | $7.1M–$300M |
|
Nippon Venture Capital
VC Fund
|
6 | Japan, United States, Indonesia | Series A, Series B | Software, Health Care, Information Technology | $1.5M–$269M |
|
Haiyuan Capital
VC Fund
|
6 | China | Series A, Seed, Angel | Manufacturing, Medical, Semiconductor | $425k–$55M |
|
Sunland Fund
VC Fund
|
5 | China | Series A, Series B, Seed | Health Care, Medical, Medical Device | $1.4M–$28M |
|
Nissay Capital
VC Fund
|
5 | Japan, United States, Ethiopia | Seed, Series A | Health Care, Information Technology, Medical | $610k–$71M |
|
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
|
5 | Japan, United States, India | Seed, Series A | Health Care, Biotechnology, Medical | $3.1M–$78M |
|
Fortune Venture Capital
VC Fund
|
5 | China, Japan, United States | Series A, Series B, Seed | Manufacturing, Software, Information Technology | $425k–$73M |
|
Mizuho Capital
VC Fund
|
5 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Internet | $1.5M–$340M |
|
Seeds Capital
VC Fund
|
5 | Singapore, United States, Hong Kong | Seed, Series A | Software, Biotechnology, Health Care | $767k–$24M |
|
Apricot Capital
VC Fund
|
5 | China, United States, Hong Kong | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $3M–$58M |
|
Huagai Capital
VC Fund
|
4 | China, United States, Germany | Series A, Series B, Angel | Health Care, Biotechnology, Medical | $425k–$147M |
|
HY Capital
VC Fund
|
4 | China, United States | Series A, Seed, Series B | Health Care, Medical, Medical Device | |
|
Keio Innovation Initiative
VC Fund
|
4 | Japan, United Kingdom | Series A, Seed | Health Care, Medical, Biotechnology | $1.5M–$64M |
|
Tsinghua Innovation Ventures
VC Fund
|
4 | China | Series A, Seed | Manufacturing, Medical, Health Care | $832k–$21M |
|
UTokyo Innovation Platform
VC Fund
|
4 | Japan, United States, United Kingdom | Series A, Series B | Biotechnology, Medical, Manufacturing | |
|
NUS Enterprise
VC Fund
|
4 | Singapore, Turkey, United States | Pre-Seed, Grant, Seed | Information Technology, Software, Health Care | $4k–$1.8M |
|
Insight Capital
VC Fund
|
4 | China | Series A, Series B, Series C | Health Care, Medical, Biotechnology | |
|
Frees Fund
VC Fund
|
4 | China, United States, Singapore | Series A, Seed, Angel | Artificial Intelligence, Health Care, Biotechnology | $425k–$35M |
|
ASBV
VC Fund
|
4 | China, Australia, Hong Kong | Seed, Series A, Angel | Health Care, Medical, Biotechnology | $425k–$31M |
| Access all 50 VC funds in Asia Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 803
- Round size: Series A $5M–$68M; Series B $9.4M–$100M; Series C $14M–$134M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $887M in 2023
Portfolio highlights
- Wholee — Wholee is a member-only zero-markup store.
- LP Amina — LP Amina focuses on products that improve coal-fired power plant's emissions and efficiency. Leveraging 50 unique patented products to improve the firing system of a coal-fired boiler, including Rotating Vane Wheels, High Performance Classifiers, Coal Pipe Balancing Technologies, and Burner Enhancements, the Company provides products andsolutions that will meet or exceed the expectations of their customers. Furthermore, LP Amina's corporate culture is one of a relentless pursuit of continuous improvement. Utilizing the latest technology and traditional know-how from the World's two largest users of Coal for power generation, the Company is well positioned to develop new products and solutions to meet the ever changing needs of Power Industry.LP Amina's staff has over 20 years of experience in the design, fabrication, installation and commissioning of coal-fired power plants. During this time, the team has gained a wide range of experience from the evolution of the US Power Market. Increases in environmental regulations and free market driven energy prices have forced plant operators to reduce emissions and improve reliability while lowering operational cost. LP Amina's engineering and design team will leverage this experience gained from the US and Europe to address the emergence of similar issues in China.
- Twine Health — Fitbit Health Solutions' wellness and health solutions can help keep your population healthy and drive meaningful employee engagement. Learn more.
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 306
- Round size: Seed $1.4M–$20M; Series A $4.3M–$41M; Series B $2.8M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $75M in 2014
Portfolio highlights
- QYSEA — QYSEA FIFISH 4K underwater video camera is combined with the world's advanced techniques, supports 20-megapixel photos shooting in various conditions. QYSEA underwater ROV drone with great durability & design. QYSEA - professional underwater drone manufacturer!
- Bytetree — Bytetree is a technology company that focuses on providing the one-stop AI data services for data collection, cleaning, labeling, management, and storage for OEMs and autonomous driving solution providers, covering bicycle intelligence. , vehicle-road coordination, and smart cockpit three scenarios.
- Yinli Electric — Ningxia Yinli Electric Co., Ltd. is mainly engaged in the production and research and development of reactors and transformers. At present, the company's main products include: three-phase filter reactors, four-phase five-column reactors, water-cooled reactors, three-phase AC reactors, hollow core Reactors, isolation transformers andhigh-frequency transformers, etc.
We help founders build enduring companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 751
- Round size: Series A $4.4M–$100M; Series B $12M–$200M; Series C $26M–$214M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
- Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
- Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 168
- Round size: Seed $7.1M–$41M; Series A $3.8M–$47M; Series B $3M–$73M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Dami&Xiaomi — Rice and millet is China's leading platform services for children with autism spectrum, from 2014 Nian 9 Yue Jiang Ying Shuang (rice) founded the "rice and millet" micro-channel public number. It now provides integrated services such as rehabilitation services, integrated education support, parent training, online courses, andpopular science information.
- CART Medical — CART Medical Technologies, Ltd. is a high-tech company specializing in the development and application of new technologies for immune cell therapy. It has a 2,200 square meter GMP laboratory and research and development laboratory.
- MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.
Show more...Investment focus
- Industry: Manufacturing, Software, Internet
- Stage:Series A, Series B, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 449
- Round size: Series A $1.4M–$43M; Series B $8.2M–$57M; Series C $20M–$100M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $1.2B in 2018
Portfolio highlights
- CertiK — CertiK, the largest Web3 security service provider, uses AI and formal verification to protect and monitor smart contracts and protocols, securing the Web3 ecosystem.
- Z.ai — Z.ai develops artificial intelligence models and services built upon large-scale pretrained architectures. The company offers ChatGLM, a dialogue-focused language model series designed for smooth conversation and easy integration. It also provides Ying, a text-to-video model capable of generating short video clips from text or images, and AutoGLM,a voice-driven AI agent that performs smartphone tasks based on complex user instructions. Z.ai supports integration through an API platform and offers migration assistance for developers moving from other AI ecosystems. The company’s technology stems from research at Tsinghua University’s KEG lab and emphasizes general-purpose cognitive intelligence models.
- Darma — DARMA - Digital Healt
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 217
- Round size: Series A $14M–$100M; Series B $25M–$110M; Series C $29M–$283M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
- ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
- Tmunity Therapeutics — Tmunity Therapeutics is developing novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), universal engineered T cell platforms, and Chimeric Antigen....
BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: China, United States, Singapore
Investor stats
- Total investments: 92
- Round size: Seed $14M–$168M; Series A $14M–$45M; Series B $14M–$150M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Huihe Healthcare — Huihe Healthcare specializes in the development of medical devices for structural heart disease. The company was founded in 2019 and is headquartered in Shanghai, China.
- LaNova Medicines — LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
- Zhiyue Space Intelligence — Zhiyue Space Intelligence specializes in robotic brain and brain systems.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: China, United States
Investor stats
- Total investments: 70
- Round size: Seed $1.4M–$15M; Series A $1.4M–$32M; Series B $7.1M–$34M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Genlight — Genlight develops innovative treatment solutions for epilepsy and other neurological diseases. Genlight is headquartered in Hangzhou, China.
- Pipi Bear —
- Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.
Show more...Investment focus
- Industry: Manufacturing, Semiconductor, Electronics
- Stage:Series A, Series B, Seed
- Geography: China, Hong Kong, Singapore
Investor stats
- Total investments: 323
- Round size: Seed $1.4k–$14M; Series A $1.4M–$28M; Series B $11M–$43M
- Lead/follow: 51% lead, 49% follow
Portfolio highlights
- Beta Infinite — Beta Infinite approaches data and model technologies in a distinctive and distinctive way.
- Letuo Technology — Letuo Technology is a ASIC chip design & manufacturing firm focused on architecture and back end design, RTL coding, DFT, and synthesis.
- Sichuan Ingia Biosynthetic — Looking for the best stevia manufacturers and wholesale suppliers? Look no further! Ingia Bio is the top natural sweetener manufacturer with a focus on precision fermentation. Find out why we're the best in the business!
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: China, United States, United Kingdom
Investor stats
- Total investments: 79
- Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Shengxin Medical — Shengxin Medical is a cardiovascular interventional medical device developer, dedicated to creating innovative, high-quality solutions that improve the diagnosis, treatment, and management of cardiovascular diseases, while advancing minimally invasive medical technologies to enhance patient outcomes and clinical efficiency.
- Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
- Kingsung Medical Group — Kingsung Medical Group operates under the Mission “Simplify Surgery, Beautiful Life,” with its innovation centered on four core technology platforms at its Tianjin base: Mechanical Design, Polymer Materials, Biodegradable Magnesium Alloys, and Collagen Biomaterials. These platforms have enabled the development of pioneering medical devices,including microvascular anastomosis devices and neural tube. In particular, the Group’s biodegradable magnesium alloy technology is spearheading the advancement of next-generation orthopedic implants. Kingsung’s technological capabilities are evidenced by a portfolio of over 190 patents and its recognition as a National Key Enterprise. The Group also actively contributes to the industry as a standing council member of the Microsurgery Branch of the China Association of Medical Devices Industry and a member of the Chinese Society for Biomaterials.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!BIOCHING CAPITAL is an investment management firm.
Show more...Investment focus
- Industry: Medical, Medical Device, Biotechnology
- Stage:Angel, Series A, Seed
- Geography: China
Investor stats
- Total investments: 20
- Round size: Angel $425k–$15M; Series A $14M–$14M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Lunke Medical — Lunke Medical focuses on the research, development, production, and sales of medical devices, with particular strength and expertise in high-pressure technologies. The company is committed to delivering safe, reliable, and innovative solutions by combining advanced engineering, strict quality control, and continuous technological advancement tomeet the evolving needs of the medical industry.
- Taose Tuantuan — Taose Tuantua is a sex toy company that primarily offers TAOSETT sex toy academy and exquisite sex toy community store services.
- Qinglan Jichuang — Qinglan Jichuang is a domestic high-performance intelligent endoscope innovative enterprise.
Taiyu Investment is an investment firm.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Series A, Angel
- Geography: China
Investor stats
- Total investments: 34
- Round size: Seed $4.1M–$14M; Series A $13M–$37M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Immunocan — Immunocan focuses on the development of fully human antibody animals, artificial chromosome carriers with independent intellectual property rights, focusing on tumor treatment, and developing antibody therapeutic drugs.
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
- Infineon Multiomics — Infineon Multiomics is a biotechnology company that provides research and application of space multiomics technology.
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 130
- Round size: Seed $772k–$43M; Series A $2.1M–$241M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- CastBio — Castbio specializes in antibody-drug conjugate-based drug discovery research and development. Along with medications, it also creates research reagents, medical equipment, in vitro diagnostic items, and offers drug discovery consulting.
- 3DC — 3DC develops and manufactures a new carbon material, graphene meso sponge (GMS), for electrodes in next-generation batteries, capacitors, fuel cells and other energy storage and generation devices.
- Formas.AI — Formas.AI is a multi-modal, AI-powered design platform specifically built for architects, designers, and educators to generate and visualize creative architectural concepts.
IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support.
Show more...Investment focus
- Industry: Software, Internet, E-Commerce
- Stage:Series A, Series B, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 752
- Round size: Series A $3M–$122M; Series B $8.3M–$141M; Series C $15M–$200M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Polymaker — Polymaker is a high quality 3D printing filament manufacturers. PLA, PETG, ABS, ASA, TPU, Nylon, PC, Carbon Fiber and more. Find the best filament for your application.
- Youxi Film Hotel — Youxi Film Hotel which is a hotel in China that combines the perfect combination of hotel and movie IP. It is also a movie hotel theme, combining film derivative industry, movie theme social space and film shooting. An integrated creative culture complex; dedicated to creating a Chinese-style movie and hotel cross-border experience hotel, breakingthrough the traditional overnight function of a traditional hotel, creating the ultimate movie experience for young people with a mindset.
- Liyang Semiconductor — Liyang Semiconductor is a power semiconductor chip developer, integrating design and development, chip manufacturing, packaging and testing
Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Series B, Angel
- Geography: China
Investor stats
- Total investments: 44
- Round size: Angel $425k–$2.8M; Series A $1.4M–$14M; Series B $10M–$71M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- XPTC — XPTC is a wafer slicing equipment developer, dedicated to the research, development, production, and sales of ultra-precision thinning cutting equipment and related consumables.
- Wuwen Zhike — Wuwen Zhixing is an intelligent driving service provider dedicated to offering professional and cutting-edge integrated solutions for AI data and simulation verification, as well as developing AI data infrastructure and accelerators.
- SynRx Therapeutics — Sanctuary Bio is a DNA damage repair drug developer, focusing on the field of DNA damage repair.
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 77
- Round size: Series A $1.4M–$76M; Series B $14M–$87M; Series C $14M–$74M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
- Carbon Life — Carbon Life is a carbon sequestration technology developer. It is mainly engaged in carbon emission reduction, carbon conversion, carbon capture, carbon sequestration technology research and development.
- Westlake Therapeutics — Q1 2022 c-suite not found.
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: China, India, Canada
Investor stats
- Total investments: 139
- Round size: Seed $450k–$5M; Series A $2.8M–$17M; Series B $2.8M–$47M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Kongshanci — Kongshanci specializes in non-invasive brain-computer interfaces and neuromodulation.
- PowerMicro — PowerMicro focuses on the cutting-edge interdisciplinary field of “stem cells + engineered scaffolds,” specializing in the application of iPSC technology to advance regenerative medicine, tissue engineering, and innovative therapeutic solutions.
- Baiyao Technology — Baiyao Technology is a biopharmaceuticals company offering drug and treatment plan development utilizing AI simulation of life processes.
Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 81
- Round size: Seed $1.2M–$117M; Series A $1.5M–$113M; Series B $7.7M–$184M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $1.1B in 2021
Portfolio highlights
- NovAccel — NovAccel operates as a deep tech company, ensure a stable supply of medical radioisotopes.
- Sonire Therapeutics — SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a noveltherapeutic modality with the goal of giving cancer patients and their families a new future.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 553
- Round size: Series A $952k–$86M; Series B $4.2M–$269M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- ADiXi — Adixi is a tech-driven business that supports the idea that people and technology may work together. It strives to open doors by utilizing cutting-edge technology, such as artificial intelligence, to promote long-term, sustainable corporate and societal progress.
- Diggle — DIGGLE is a service that provides fundamental management accounting management on the cloud called fraud management. It is possible to reduce the mistakes and man-hours of the fraud management task and easily carry out the fraud management task even if it is not an expert in finance or accounting.DIGGLE covers budget creation work and budgetrecord comparison work, especially in the foreman management work. In the budget creation work, the KPI and the budget are automatically created by inputting the target numerical value to the preset parameters utilizing the budget generator function, while the forecast contrasting work is made up of the financial information, non-financial information It is easy to calculate by simply entering the numerical value, and it is possible to carry out calculation of the forecast contrast.
- Luxna Biotech — Luxana Biotech is established to contribute to medical treatment for suffering patients, .
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 80
- Round size: Seed $8M–$60M; Series A $2.8M–$40M; Series B $11M–$60M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $69M in 2019
Portfolio highlights
- Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
- Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
- Beijing Ansong Technology — Beijing Ansong Technology Co., Ltd. is an enterprise focusing on the research and development, production, and sales of orthopedic medical devices. The company cooperates with domestic and foreign universities, research institutes, and doctors in hospitals, and is committed to creating original orthopedic products with independent knowledgeproducts.Beijing Ansong Technology was founded on June 27, 2011 by Liang Tao in Fengtai, Beijing.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: China, United States, South Korea
Investor stats
- Total investments: 410
- Round size: Series A $2.9M–$93M; Series B $12M–$115M; Series C $14M–$156M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $177M in 2021
Portfolio highlights
- Pony.ai — Pony.ai is a startup that builds full-stack autonomous driving solutions. It is a pioneer in autonomous mobility technologies and services across the US and China, spearheading public-facing Robotaxi pilots in both markets. Pony.ai is committed to creating a safe and sustainable mobility future by delivering autonomous mobility everywhere.Thecompany was founded by James Peng and Tiancheng Lou in 2016 and is headquartered in Fremont, California, United States.
- Sifli Technologies — Sifli Technologies focuses on the design and application development of embedded artificial intelligence IoT platforms.
- Biortus — Wuxi Biortus Biosciences is an innovation-driven contract research organization (CRO) committed to high-quality R&D services in support of drug discovery.To help our clients achieve their drug discovery goals, we have established five world-class research platforms. These are Recombinant Protein Production, Structural Biology (X-rayCrystallography and Cryo-EM), In Vitro Assays and Screening, Medicinal Chemistry, and Process Development. Through the years, our R&D team has developed a number of practical and innovative techniques of which some have already been granted patent.
Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Medical
- Stage:Series A, Seed, Angel
- Geography: China, United States, Singapore
Investor stats
- Total investments: 146
- Round size: Seed $213k–$25M; Angel $425k–$14M; Series A $1.4M–$60M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Huihe Healthcare — Huihe Healthcare specializes in the development of medical devices for structural heart disease. The company was founded in 2019 and is headquartered in Shanghai, China.
- Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
- Xiaolong Technology —
Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 63
- Round size: Seed $7M–$13M; Series A $1.4M–$16M; Series B $14M–$462M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Fungifuture — Fungifuture is a synthetic biomaterials company specializing in the research and development and production of fungal fiber materials.
- Ruize Health — Ruize Health is a commercial insurance company that focuses on health consumption and commercial insurance.
- Fuxin Technology Innovation — Fuxin Kechuang is a high-tech company that specializes in offering detailed information solutions for the medical and healthcare industries. The business offers creative software solutions and services to a range of healthcare organizations, actively supports the digital transformation of healthcare, and uplifts the medical sector. The company hasgained recognition and has become a partner of big and medium-sized medical institutions and healthcare institutions by relying on its technological research and development power, service capabilities, and ecosystem of medical and health software.
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more...Investment focus
- Industry: Software, Information Technology, Financial Services
- Stage:Series B, Series A
- Geography: Japan, South Korea, United States
Investor stats
- Total investments: 375
- Round size: Series A $2M–$156M; Series B $4.9M–$227M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $1.1B in 2020
Portfolio highlights
- LQUOM — QWAVE offers cryptography communication technology.
- Direava — Direava is a medical device company that manufactures, sells, leases, and maintains medical equipments along with consulting services.
- Zerodoor HD — Zerodoor HD specializes in digital transformation in constructing industry.
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: China, United States, Singapore
Investor stats
- Total investments: 459
- Round size: Seed $1.6M–$32M; Series A $2.9M–$57M; Series B $10M–$113M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- TT Yuyin — Quwan provides services including instant voice messaging, social gaming, esports, and game distribution. It operates TT Voice, which started as a voice chat application designed for mobile gamers and was later developed into a social gaming platform. It focuses on developing personalized services for the Gen Z audience.
- Huangbaoche — Huangbaoche is a travel service providing tour packages and booking services. Huangbaoche has over 100,000 Chinese-speaking drivers and tour guides providing airport pick-up services, chartered car services, and guided tours in over 1,500 overseas travel destination cities in 80 countries.
- Jiajin Biotech — Jiajin Biotech is a pharmaceutical R&D service provider. It specializes in the development of antibody-small nucleic acid conjugates.
SND Ventures Group is a venture capital and private equity firm specializing in seed investments.
Show more...Investment focus
- Industry: Manufacturing, Semiconductor, Health Care
- Stage:Series A, Series B, Seed
- Geography: China
Investor stats
- Total investments: 81
- Round size: Series A $1.4M–$21M; Series B $1.4M–$28M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Audfly Technology — Audfly is a high-tech ultrasonic directional speaker company that owns directional advanced audio technology and has different types of directional loudspeakers for sale. We have many years of experience in researching super directional speaker in China. We are centered on quality and innovation to provide parametric speaker. Click for our parametr
- Jipai Electromagnetic — Jipai Electromagnetic specializes in the manufacture of automobile components and accessories.
- Sicui Thermal Control — Sicui Thermal Control focuses on the design of next-generation semiconductor and microelectronics thermal management solutions.
Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: China, United States, Canada
Investor stats
- Total investments: 195
- Round size: Series A $1.7M–$55M; Series B $10M–$100M; Series C $14M–$200M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- ChipSine — ChipSine is an Integrated Circuit (IC) design company that focuses on the research and development of automotive-grade electronic control chips.
- Empower — Empower is an enterprise platform focused on intelligent laser manufacturing that makes lasers smart.
- Neowise — XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Series B
- Geography: Japan, United States, Israel
Investor stats
- Total investments: 295
- Round size: Series A $1.9M–$170M; Series B $7M–$198M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- CaTe —
- EISHIN — EISHIN is a technology company that specializes in pet tech business, recruitment consulting, website creation, and development services.
- Yokohama Vanilla — Yokohama Vanilla is a Company which operates Yokohama-based gift sweets brand.
SZHTI Group is a company that provides asset management and financing services.
Show more...Investment focus
- Industry: Manufacturing, Electronics, Semiconductor
- Stage:Series A, Angel
- Geography: China, United States
Investor stats
- Total investments: 126
- Round size: Angel $425k–$1.4M; Series A $780k–$14M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Menovex — Mir Medical Technology is a laser minimally invasive medical treatment enterprise, offering devices, core components, and modules in oral, urological, skin, and vascular fields. With independent research and development capabilities and international marketing, it provides full-cycle laser medical ODM services to domestic and foreign industrypartners.
- Junyi Technology — Shenzhen Junyi Technology Co., Ltd. is one of the world's leading OLED vapor deposition metal mask manufacturers. Its business includes OLED metal mask R&D, production and manufacturing, as well as supporting cleaning and maintenance services. Its customers cover CSOT, Truly Semiconductor, Royole Technology, Wuhan Tianma, BOE and otherdomestic OLED panel companies.
- Yingshen Intelligence — Yingshen Intelligence is a robot developer that focuses in the research, growth, and application of embodied intelligence technology.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, South Korea
Investor stats
- Total investments: 166
- Round size: Seed $10M–$73M; Series A $2.8M–$74M; Series B $7.6M–$70M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $563M in 2021
Portfolio highlights
- Approaching.AI — Approaching.AI is an AI Infra company focusing on the important large model application scenarios such as RAG.
- Xingneng Xuanguang — Xingneng Xuanguang is a fusion energy company that specializes in the development of advanced field reverse magnetic mirror fusion path technology.
- Blue Vector Intelligent — Blue Vector Intelligent is a company primarily engaged in software and information technology services, specializing in the development of intelligent software solutions, data-driven platforms, and digital transformation technologies.
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Series A, Series B, Series C
- Geography: China, United States, Canada
Investor stats
- Total investments: 285
- Round size: Series A $7.1M–$100M; Series B $14M–$142M; Series C $14M–$300M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- HitGen — HitGen is provides biological reagents and services to support drug discovery research.
- ZSPepLib — Zonsen PepLib Biotech Inc. Zonsen PepLib Biotech Inc. is a high-tech biopharmaceutical enterprise that is dedicated to advancing global innovation in the discovery of new peptide drugs. Founded in September 2017, PepLib is headquartered in Zhuzhou, China, with a subsidiary in New Jersey, USA.
- Eyegood Ophthalmic Hospital — Eyegood Ophthalmic Hospital is a ophthalmology hospital.
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Series B
- Geography: Japan, United States, Indonesia
Investor stats
- Total investments: 169
- Round size: Series A $1.5M–$74M; Series B $3.3M–$269M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — raised $278M in 2023
Portfolio highlights
- Menou — MENOU specializes in AI technology and sensing technology. It features a graphical image identification modeler software.
- Space BD — Space BD aims to become a one-stop shop to respond to all issues related to industrialization of space, and alleviate the work of businesses that are developing new technologies.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Goldport Capital is a Shenzhen-based asset management company.
Show more...Investment focus
- Industry: Manufacturing, Medical, Semiconductor
- Stage:Series A, Seed, Angel
- Geography: China
Investor stats
- Total investments: 68
- Round size: Seed $1.4M–$15M; Angel $425k–$14M; Series A $1.4M–$55M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- Anxin Medical — Anxin Medical is a company dedicated to the research, development, production, and sales of innovative medical devices. The company focuses on advancing healthcare technology through continuous innovation, integrating cutting-edge science and engineering to create high-quality, reliable, and efficient medical products.
- Kejicheng Store Technology — Kejicheng Store Technology is an AI-driven retail technology company specializing in location intelligence and data-backed site selection. Incubated by the pop-up space marketplace Linhuiba, the firm treats physical storefronts and real-world foot traffic similarly to online programmatic advertising vectors. By deploying Graph Neural Networks andlocation embedding models across millions of data points, it predicts precise metrics like store entry rates and market cannibalization. The company actively provides its network planning, decision-making, and A/B testing software to numerous regional chains and eight massive brands boasting over 10,000 stores each.
- Zhishu Intelligent Technology — Zhishu Intelligent Technology provides precision diagnostics and therapies for cancer by by using AI technologies.
Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Seed
- Geography: China
Investor stats
- Total investments: 33
- Round size: Seed $1.4M–$14M; Series A $1.4M–$14M; Series B $2.8M–$28M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Aopeng Yiliao — Aopeng Yiliao is a developer of vascular interventional surgery robots.
- Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
- Yangshan Medical Technology — Yangshan Medical Technology is a Shanghai-based company specializing in dental surgery robots.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more...Investment focus
- Industry: Health Care, Information Technology, Medical
- Stage:Seed, Series A
- Geography: Japan, United States, Ethiopia
Investor stats
- Total investments: 257
- Round size: Seed $610k–$43M; Series A $2M–$71M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- Global Trust Networks — Global Trust Networks is a company that helps foreigners to live in Japan
- Fabric Tokyo — FABRIC TOKYO is a Japanese startup provides a direct-to-consumer custom-made apparel brand. (former-company name Lifestyle Design Co., Ltd.). It enables customers to save their sizes, idea fabrics, and favorite designs, allowing them to make their original clothing later.FABRIC TOKYO was founded in 2012 by Yuichiro Mori and is based in Tokyo,Japan.
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 182
- Round size: Seed $3.1M–$48M; Series A $3.6M–$78M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- TXP Medical — TXP Medical build a next-generation medical system through acute care.
- Startbahn — Startbahn develops Startrail, a sustainable and scalable blockchain infrastructure that assures the reliability, authenticity, and traceability of artworks.
Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Series A, Series B, Seed
- Geography: China, Japan, United States
Investor stats
- Total investments: 271
- Round size: Seed $425k–$73M; Series A $1.4M–$70M; Series B $2.8M–$57M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $780M in 2021
Portfolio highlights
- Transcenta — Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture, focusing on developing innovative antibodies to help more patients. HJB and MabSpace Biosciences merged and created Transcenta.
- Sandstone — SandStone is a product, solution and service provider focused on next-generation data storage (ServerSAN), which is dedicated to helping users cope with data storage, traffic and data management complexity, helping users build storage virtualization and Computation of virtualization as the core cloud computing infrastructure environment, andgradually provide data processing, mining, analysis and intelligence in the field of big data professional systems and services.
- Xinjie Energy — Xinjie Energy focuses on the research, development, and production of lithium metal solid-state batteries. These batteries aim to offer energy density and improved safety compared to traditional lithium-ion batteries. The company works on advancing battery technology, with potential applications in electric vehicles and energy storage. It isinvolved in advancing solid-state battery technology and expanding its presence in the battery industry.
Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more...Investment focus
- Industry: Information Technology, Software, Internet
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 460
- Round size: Series A $1.5M–$115M; Series B $2.4M–$340M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- CaTe —
- FunPep — FunPep is an Industry-university collaboration bioventure company.
- NEXT NEW WORLD — NEXT NEW WORLD develops and manufactures natural products with low impact on the environment. It uses sustainable Japanese silk to manufacture apparel and cosmetic products.
Catalysing smart monies into Singapore-based, early-stage technology startups.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: Singapore, United States, Hong Kong
Investor stats
- Total investments: 142
- Round size: Seed $767k–$6M; Series A $3.5M–$24M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- HealthBeats — HealthBeats is a product based on their belief,regular monitoring outside of healthcare settings will only lead to better results.
- ChemT Biotechnology — The goal of ChemT Biotechnology is to increase patient access to the most cutting-edge biologics, beginning with the urgent issues in manufacturing and research and development.
- Protuoso Biosciences — Protuoso Biosciences is a biotechnology company developing next-generation multifunctional biologics designed to address complex disease biology.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 46
- Round size: Seed $10M–$41M; Series A $3M–$54M; Series B $14M–$58M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- iRegene — iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases.
- Vibrant — Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects tocontinuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization.It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.
- Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Angel
- Geography: China, United States, Germany
Investor stats
- Total investments: 136
- Round size: Angel $425k–$15M; Series A $1.4M–$63M; Series B $3.5M–$147M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $430M in 2018
Portfolio highlights
- SenseTime — SenseTime Medical is an AI healthcare firm that creates solutions for hospitals, research institutions, and the global medical market. Through its SenseCare platform, the company provides over 40 specialized AI modules and maintains strategic partnerships with organizations like Roche, Midea, and Ruijin Hospital to streamline patient services andmedical innovation.
- GigaAI — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
- Falcon Technology — Falcon Technology focuses on DSA processor design innovation, developing a dedicated computing technology ecosystem based on the RISC-V architecture to deliver high-performance, energy-efficient processing solutions for next-generation intelligent computing applications.
HY Capital is a healthcare industry-focused investment firm that engages in early-stage investments, growth-stage investments.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Seed, Series B
- Geography: China, United States
Investor stats
- Total investments: 20
- Lead/follow: no public data
Portfolio highlights
- Kang Ruijian — Kang Ruijian is a developer of thermosensitive modified chitin hydrogel technology.
- Onico Medical — Onico Medical is a medical device developer. The core team comes from the serious medical field and has absorbed professionals with rich experience in medical aesthetics development.
- Linyan Medical — Linyan Medical is a high-tech company focusing on the combination of man and machine in metaverse medical surgery.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: Japan, United Kingdom
Investor stats
- Total investments: 87
- Round size: Seed $1.5M–$57M; Series A $2.3M–$64M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- Grafenary — Graphenary creates unique graphene optical devices using graphene materials with a variety of remarkable features.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Tsinghua Innovation Ventures is an investment management firm.
Show more...Investment focus
- Industry: Manufacturing, Medical, Health Care
- Stage:Series A, Seed
- Geography: China
Investor stats
- Total investments: 91
- Round size: Seed $832k–$15M; Series A $1.4M–$21M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- ChipLife — CoreVision is a firm focused on the study and development of high-precision neural signal capture and closed-loop modulation technology.
- ROBO Medical — ROBO Medical is a medical robot research and development company.
- Ciyuan Infinite Technology — Ciyuan Infinite Technology is an AI programming technology company that provides programming support for enterprises.
The University of Tokyo IPC is a company responsible for expanding the innovation ecosystem of the University of Tokyo. Accelerate global innovation from the University of Tokyo through three activities: start-up support, investment business, and corporate innovation support.It was established as a wholly-owned subsidiary of the University ofTokyo in 2016 with the enforcement of the revised law of the Industrial Competitiveness Enhancement Law, which is the basis law. The investment targets of the Todai IPC are venture companies that utilize the research results and human resources of the University of Tokyo, but they also make FOF (fund of funds) investments in funds managed by some private venture capital companies. In 2019, it started a consortium-type incubation program (University of Tokyo IPC 1stRound) to support the establishment and financing of Tokyo University-related ventures.
Show more...Investment focus
- Industry: Biotechnology, Medical, Manufacturing
- Stage:Series A, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 65
- Lead/follow: no public data
Portfolio highlights
- Issin — Issin manufactures bath mats that can measure weight and automatically record daily weight changes on your smartphone.
- RoboTruck — RoboTruck develops autonomous driving technologies for huge trucks, as well as practical applications.
- Leading Mark — Leading Mark, a rising human resources startup in Japan. Leading Mark is branching out into mid-career and international hiring. It currently has a one-man team in China working to bring the top Japanese-speaking Chinese students to domestic companies. He also touts his startup’s focus on the average job seeker. “We want to make sure that the usersget the info that he or she needs the most,” he says. Large scale, legacy players can sometimes prioritize the needs of the hiring company, and their commission, over the needs of applicants themselves. This leads to frustration and short-circuited careers.
NUS Enterprise provides an entrepreneurial and innovative dimension to the National University of Singapore’s core research and educational activities.By encouraging the entrepreneurial spirit, partnering for success, and nurturing future entrepreneurial leaders, NUS Enterprise aims to make a positive impact on Singapore’s economy and beyond.This is done through three key thrusts: entrepreneurship support, industry engagement and partnerships, and experiential education.NUS Enterprise was founded in 2001 and is based in Singapore.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Pre-Seed, Grant, Seed
- Geography: Singapore, Turkey, United States
Investor stats
- Total investments: 18
- Round size: Seed $4k–$1.8M; Grant $6k–$8k; Pre-Seed $22k–$600k
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Guardara — The most comprehensive negative testing / fuzz testing platform to hunt down bugs and zero-day vulnerabilities.
- Telequotes — At Telequotes, we are revolutionising the selling experience by seamlessly connecting sellers to ready buyer. Our platform bridges the C2B market gap, offering sellers a hassle-free experience with transparent, competitive pricing from our trusted partners.With a commitment to transparency and value, Telequotes ensures sellers get the best pricepossible, all in one place.
- Responsible Cyber with IMMUNE — Responsible Cyber Landing Page
Insight Capital is a venture capital firm focused on early-stage investment.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: China
Investor stats
- Total investments: 23
- Lead/follow: no public data
Portfolio highlights
- Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
- Amity Solutions — Enterprise Chatbots, AI-based generative Chatbots, pre-built social features for apps and websites, and building blocks for employee experiences.
- Iongen Therepeutics — Discovery of Novel Analgesics IonGen is a biotech company dedicated to the discovery of next-generation pain therapies without the addiction liabilities and side-effects associated with opioids.
By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Biotechnology
- Stage:Series A, Seed, Angel
- Geography: China, United States, Singapore
Investor stats
- Total investments: 213
- Round size: Seed $1.4M–$14M; Angel $425k–$17M; Series A $1.4M–$35M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $130M in 2015
Portfolio highlights
- SoundAI — Sound Technology is a science and technology innovation company that specializes in acoustics frontier technology and artificial intelligence interaction. It is committed to lead the more interactive experience of artificial intelligence in the real environment and realize the human-computer interaction vision that "listen to you and know whatyou think".
- Methuselah — Methuselah is a research and development manufacturer of medical nutritional food.
- Jiajin Biotech — Jiajin Biotech is a pharmaceutical R&D service provider. It specializes in the development of antibody-small nucleic acid conjugates.
ASBV focuses on early and mid-term venture capital investments.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Angel
- Geography: China, Australia, Hong Kong
Investor stats
- Total investments: 27
- Round size: Seed $3M–$14M; Angel $425k–$425k; Series A $1.4M–$31M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in Asia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Asia Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!